A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
Clinical trial NCT03648827 · COMPLETED
Trial details
- NCT number
- NCT03648827
- Sponsor
- PTC Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-21
- Primary completion
- 2020-10-23
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.